Facebook
Twitter
LinkedIn
Forward2019 Dennis G. Maki Infectious Disease Update Conference
This conference is dedicated to Dennis G. Maki, MD, Emeritus Professor, Department of Medicine, University of Wisconsin School of Medicine and Public Health, in recognition of his achievements and contributions as a physician, scholar, and educator in the field of Infectious Disease.
STATEMENT OF NEED
Based on documented gaps in current practice, this activity addresses critical topics in Infectious Diseases identified through professional practice; local, regional and national data in healthcare quality; and requests from participants in related continuing education activities. The overall focus of this activity is to discuss these practice gaps and provide participants with the knowledge, skills, tools and resources needed to change their professional practice and improve the care of their patients.
INTENDED AUDIENCE & SCOPE OF PRACTICE
This activity is intended for primary care physicians, physician assistants, nurses, pharmacists, and other health care specialists dealing with infectious diseases.
ELEMENTS OF COMPETENCE
This activity has been designed to change learner competence and focuses on the American Board of Medical Specialties areas of patient care and procedural skills, medical knowledge, and professionalism. This activity also focuses on the interprofessional competencies of teams/teamwork, and values/ethics.
OBJECTIVES
This activity is designed to:
- Prevent, accurately diagnose, and optimally treat infectious diseases conditions commonly seen by the primary care health care team
- Employ new strategies to enact behavior change in patients
- Explain updated practice guidelines
Additional Information
| Attachment | Size |
|---|---|
 2019 Dennis G. Maki ID Brochure.pdf | 12.64 MB |
AGENDA | |
FRIDAY, DECEMBER 13 | |
| AM | |
| 7:00 | Registration, Breakfast |
| 7:55 | Welcome, David R. Andes, MD |
| 8:00 | Foodborne Infections, Dennis G. Maki, MD |
| 9:00 | Badger State Bugs: Pathogens Endemic to Wisconsin, Gregory M. Gauthier, MD, MS |
| 9:30 | To PCV or Not to PCV? Update on Advisory Committee on Immunization Practices (ACIP) Vaccine Recommendations, Jonathan L. Temte, MD, PhD |
| 10:00 | Question and Answer Period |
| 10:15 | Refreshment Break, View Exhibits |
| 10:30 | Birds, Sushi and Bat Caves: Cases You'll Enjoy, Lindsay N. Taylor, MD |
| 11:00 | Not Again! Approach to Recurrent UTI, Cellulitis and Pneumonia, Alexander J. Lepak, MD |
| 11:30 | Kill the Bugs, Save the Drugs: Cutting Edge Stewardship for the Emergency Department and Urgent Care, Michael S. Pulia, MD, MS |
| 12:00 | Question and Answer Period |
| PM | |
| 12:15 | Lunch, View Exhibits |
| 1:15 | Infectious Disease Jeopardy, Joseph A. McBride, MD, MA, DTM&H |
| 1:45 | Treating Hepatitis C in Primary Care Settings: The Time is Now! Ryan P. Westergaard, MD, PhD, MPH |
| 2:15 | A Wicked Problem: Clostridioides difficile Infection, Nasia Safdar, MD, PhD |
| 2:45 | Question and Answer Period |
| 3:00 | Refreshment Break, View Exhibits |
| 3:15 | When Big Toes Are Big Problems: Diabetic Foot Ulcer Management, Meghan B. Brennan, MD, MS |
| 3:45 | Probiotics: Gift from the Gods or Load of Waste, Joseph A. McBride, MD, MA, DTM&H |
| 4:15 | Call Me Maybe Definitely: Tough Cases We Can Help With, Jessica S. Tischendorf, MD, MS |
| 4:45 | Question and Answer Period |
| 5:00 | Adjourn |
SATURDAY, DECEMBER 14 | |
| AM | |
| 7:00 | Breakfast, View Exhibits |
| 7:55 | Welcome, Andrew W. Urban, MD |
| 8:00 | STDs in 2020 - It's a Scary World Out There, Andrew W. Urban, MD |
| 8:30 | Are You PrEPared? HIV Pre-Exposure Prophylaxis for the Primary Care Clinician, Rose A. Staden, NP |
| 9:00 | Stewardship That Everyone Can Use, Lucas T. Schulz, PharmD, BCPS (AQ-ID) |
| 9:30 | Question and Answer Period |
| 9:45 | Refreshment Break, View Exhibits |
| 10:00 | Infectious Disease Guideline Updates: Notes from the Field, Ambar Haleem, MD |
| 10:30 | When Your Patient's Immune System Is Not All There, Jeannina A. Smith, MD |
| 11:00 | Sepsis Update, Dennis G. Maki, MD |
| 12:00 | Question and Answer Period |
| 12:15 | Adjourn |
Conference Housing
A block of rooms has been reserved at the conference site, The Glacier Canyon Lodge. Please contact the hotel directly (1-800-867-9453) to arrange your accommodation. The special rates are:
- $99.99 (plus tax and resort fee) for a Double Queen Couch Glacier Canyon Lodge Room
- $140 (plus tax and resort fee) for a 2 Bedroom Glacier Canyon Deluxe Room
- $239 (plus tax and resort fee) for a 3 Bedroom Glacier Canyon Deluxe Room
When making your reservation, please tell the reservation agent that you are booking a room under the 2019 UW Dennis G. Maki Infectious Disease Update at Glacier Canyon Lodge, Leader #718679. The block of rooms will be held on a first-come, first-served basis and any available rooms that have not been reserved by November 12, 2019, will be released to the general public.
PLANNING COMMITTEE
University of Wisconsin School of Medicine and Public Health
David R. Andes, MD, William A. Craig Endowed Professor of Medicine and Division Head, Division of Infectious Disease
Lucas T. Schulz, PharmD, BCPS (AQ-ID), Department of Pharmacy, UW Health
Rose A. Staden, NP, Nurse Practitioner, Division of Infectious Disease
Jonathan L. Temte, MD, PhD, Professor of Family Medicine and Community Health
Andrew W. Urban, MD, Professor of Medicine, Division of Infectious Disease
FACULTY
University of Wisconsin School of Medicine and Public Health
David R. Andes, MD, William A. Craig Endowed Professor of Medicine and Division Head, Division of Infectious Disease
Meghan B. Brennan, MD, MS, Assistant Professor of Medicine, Division of Infectious Disease
Gregory M. Gauthier, MD, MS, Associate Professor of Medicine, Division of Infectious Disease
Ambar Haleem, MD, Clinical Assistant Professor of Medicine, Division of Infectious Disease
Alexander J. Lepak, MD, Assistant Professor of Medicine, Division of Infectious Disease
Dennis G. Maki, MD, Ovid O. Meyer Professor of Medicine, Divisions of Infectious Disease and Pulmonary/Critical Care Medicine; Attending Physician, Center for Trauma and Life Support and eICU
Joseph A. McBride, MD, MA, DTM&H, Clinical Assistant Professor of Medicine (Division of Infectious Disease), and Pediatrics (Division of Infectious Diseases)
Michael S. Pulia, MD, MS, Assistant Professor of Emergency Medicine
Nasia Safdar, MD, PhD, Professor of Medicine, Division of Infectious Disease, and Vice Chair of Research and Development, Department of Medicine
Lucas T. Schulz, PharmD, BCPS (AQ-ID), Department of Pharmacy, UW Health
Jeannina A. Smith, MD, Clinical Associate Professor of Medicine, Director of Transplant Infectious Disease, and Infectious Disease Fellowship Program Director, Division of Infectious Disease
Rose A. Staden, NP, Nurse Practitioner, Division of Infectious Disease
Lindsay N. Taylor, MD, Fellow, Division of Infectious Disease
Jonathan L. Temte, MD, PhD, Professor of Family Medicine and Community Health
Jessica S. Tischendorf, MD, MS, Fellow, Division of Infectious Disease
Andrew W. Urban, MD, Professor of Medicine, Division of Infectious Disease
Ryan P. Westergaard, MD, PhD, MPH, Associate Professor of Medicine, Division of Infectious Disease
Policy on Faculty and Sponsor Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s). Detailed disclosures will be made available in the activity handout materials.
NAME |
ROLE |
FINANCIAL RELATIONSHIPS DISCLOSURE | DISCUSSION OF UNLABELED/ UNAPPROVED USES OF DRUGS/DEVICES IN PRESENTATION? |
David R. Andes, MD | Planner | Amplyx Pharmaceuticals, Cidara Therapeutics, Crestone, Melinta Therapeutics, Inc., Merck, Paratek, Wockhardt Pharmaceuticals (Grants) |
No |
Meghan B. Brennan, MD, MS | Presenter | No relevant financial relationships to disclose | No |
Gregory M. Gauthier, MD, MS | Presenter | No relevant financial relationships to disclose | No |
Ambar Haleem, MD | Presenter | No relevant financial relationships to disclose | No |
Alexander J. Lepak, MD | Presenter | No relevant financial relationships to disclose | Yes |
Dennis G. Maki, MD | Presenter | No relevant financial relationships to disclose | Yes |
Joseph A. McBride, MD, MA | Presenter | No relevant financial relationships to disclose | Yes |
Cathy J. Means, MS | Planner | No relevant financial relationships to disclose | No |
Michael S. Pulia, MD, MS | Presenter | No relevant financial relationships to disclose | No |
Nasia Safdar, MD, PhD | Presenter | No relevant financial relationships to disclose | No |
Lucas T. Schulz, PharmD, BCPS | Planner, Presenter | Merck (Primary Investigator); Astellas (Speaker) | No |
Jeannina A. Smith, MD | Presenter | No relevant financial relationships to disclose | Yes |
Rose A. Staden, NP | Planner, Presenter | No relevant financial relationships to disclose | No |
Lindsay N. Taylor, MD | Presenter | No relevant financial relationships to disclose | No |
Jonathan L. Temte, MD, PhD | Planner, Presenter | Elsevier Publishing (Advisory Board Member); Merck Vaccines (Expert Witness); Quidel Corporation (Principal Investigator) | No |
Jessica S. Tischendorf, MD, MS | Presenter | No relevant financial relationships to disclose | No |
Andrew W. Urban, MD | Planner, Presenter, Content Reviewer | No relevant financial relationships to disclose | Yes |
Ryan P. Westergaard, MD, PhD | Presenter | No relevant financial relationships to disclose | No |
* The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Accreditation Statement
 | In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Statement
 | American Board of Internal Medicine: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. |
American Academy of Family Physicians (AAFP)
This Live activity, 2019 Dennis G. Maki Infectious Disease Update Conference, with a beginning date of 12/13/2019, has been reviewed and is acceptable for up to 11.50 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC) & Iowa Board of Nursing
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 11.5 ANCC and Iowa contact hours. ANCC pharmacotherapeutic contact hours will be calculated and awarded as appropriate to meet the needs of advanced practice nurses. The University of Wisconsin–Madison School of Nursing is Iowa Board of Nursing provider 350. A copy of the evaluation may be sent to the Iowa Board of Nursing, 400 SW 8th Street, Suite B, Des Moines, IA 50309.
Accreditation Council for Pharmacy Education (ACPE)
The University of Wisconsin–Madison ICEP designates this knowledge-based activity for a maximum of 11.5 hours (1.15 CEUs) of CPE credit. Credit can be earned by documented attendance and by successfully completing the assessment. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.
Universal Activity Number (UAN) JA0000358-0000-19-088-L01-P; 11.5 hours/1.15 CEUs.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 1.15 continuing education units (CEUs) or 11.5 hours.
Available Credit
- 11.50 MOC: ABIM Medical Knowledge Points (Part II)
- 11.50 ACPE Contact Hours - Pharmacist
- 11.50 AMA PRA Category 1 Credit™
- 11.50 ANCC Contact Hours
- 11.50 Iowa Board of Nursing Contact Hours
- 11.50 University of Wisconsin–Madison Continuing Education Hours
CANCELLATION AND REFUND POLICY
Requests for cancellation must be submitted in writing to [email protected]. Cancellation requests received at least 96 hours prior to the conference will allow a full refund except for the nonrefundable processing fee of $50. No refunds will be made for cancellations received less than 96 hours prior to the activity start date.
QUESTIONS ABOUT REGISTRATION
Email [email protected] or call 608-262-7226.
PROGRAM CHANGES
Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin School of Medicine and Public Health and the University of Wisconsin–Madison ICEP reserve the right to alter or substitute a topic or speaker without prior notification.
FOR FURTHER INFORMATION
For registration assistance please contact Dylan Rindo at [email protected]; for all other questions please contact Cathy Means at [email protected].